Alzheimer's disease (AD) causes gradual cognitive decline and dementia.
Until recently, the definitive diagnosis of AD was based on autopsy assessments of brain amyloid-β plaques and tau neurofibrillary tangles, the defining biological features of AD. Biomarkers of amyloid-β and tau are vital for measuring AD pathology in living people and for differentiating between different neurodegenerative diseases.
With the latest progress in AD research, accurate in-vivo diagnosis of AD is becoming increasingly crucial: before starting treatment with anti-amyloid therapies, it's essential to determine if amyloid positivity is present. This article...
A new study suggests lithium could help reverse Alzheimer's disease. Dr. Howard Weiner, who helped develop a nasal spray aimed at slowing Alzheimer’s, tells...
Dr. Howard Whiner, a neurologist at Mass General Brigham who helped develop a nasal spray aimed at slowing Alzheimer’s, joins NewsNation to discuss new...
Dr. Ali Rezai told 60 Minutes that new developments in blood testing could help doctors identify patients who are at risk for Alzheimer's disease.
"60...
A Houston doctor believes a new drug being studied there offers a huge breakthrough in Alzheimer’s disease
Subscribe to FOX 4:
Dallas news, weather, sports...
A new study published in Nature (Aug 2025) suggests that lithium may play an important role in brain health and protection against Alzheimer’s disease....
Carolyn Clevenger is a geriatric nurse practitioner at Emory University, where she leads the Integrative Memory Care Clinic. Carolyn cares for patients living with...
Alzheimer's disease is a type of #dementia that affects memory, thinking, and behavior.
Learn about the four "A's" of Alzheimer's disease—#amnesia, #aphasia, #apraxia, and...